Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate AD Subjects
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04251182 |
|
Recruitment Status :
Suspended
(COVID-19 Panemic)
First Posted : January 31, 2020
Last Update Posted : February 3, 2021
|
Sponsor:
T3D Therapeutics, Inc.
Collaborators:
National Institute on Aging (NIA)
Clinilabs, Inc.
Alzheimer's Association
Information provided by (Responsible Party):
T3D Therapeutics, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Suspended |
|---|---|
| Estimated Primary Completion Date : | September 2022 |
| Estimated Study Completion Date : | September 2022 |